Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |